Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4)

Michelle A. Neben-Wittich, Pamela J. Atherton, David J. Schwartz, Jeff A. Sloan, Patricia C. Griffin, Richard L. Deming, Jon C. Anders, Charles L. Loprinzi, Kelli N. Burger, James A. Martenson, Robert C. Miller

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy